In the light of significantly higher serum TPO level among CIT patients [39, 40], medical treatment other than recombinant TPO and TPO receptor agonist may be needed to recover thrombocytopenia without causing possible thrombosis, myelofibrosis, and even thrombocytosis [7]. This evidence concerns the gene TPO and Thrombocytosis.